Free Trial
LON:ETX

e-therapeutics (ETX) Share Price, News & Analysis

e-therapeutics logo

About e-therapeutics Stock (LON:ETX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
9
9
52-Week Range
N/A
Volume
2.52 million shs
Average Volume
758,869 shs
Market Capitalization
£52.59 million
P/E Ratio
N/A
Dividend Yield
3.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ETX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ETX Stock News Headlines

Jeff Bezos Launches "ChatGPT Killer"?
Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story. Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future. But one tiny startup—not Amazon—may offer the bigger upside.
See More Headlines

ETX Stock Analysis - Frequently Asked Questions

e-therapeutics plc (LON:ETX) issued its quarterly earnings data on Tuesday, March, 17th. The company reported ($0.87) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.03.

Shares of ETX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that e-therapeutics investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), B&M European Value Retail (BME), Coats Group (COA), Eurasia Mining (EUA), genedrive (GDR) and Greencore Group (GNC).

Company Calendar

Last Earnings
3/17/2020
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ETX
CIK
N/A
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.06 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-38.75%
Return on Assets
-29.10%

Debt

Debt-to-Equity Ratio
0.33
Current Ratio
22.20
Quick Ratio
20.13

Sales & Book Value

Annual Sales
£295 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.07
Book Value
GBX 5 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
584,330,000
Free Float
N/A
Market Cap
£52.59 million
Optionable
Not Optionable
Beta
0.46
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:ETX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners